The Trifecta of Polo-Like Kinases, Cancer, and the Immune System: Emerging Intersections and Therapeutic Insights
- 23 March 2026
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 24 (6) , 444-457
Abstract
Cancer remains one of the most pressing global health challenges, with immunotherapy being a promising treatment option. However, numerous clinical challenges, such as recurrence and resistance, persist, underscoring the urgent need for a deeper understanding of the mechanisms that influence immune responses in cancer. Polo-like kinases (PLK), a family of enzymes with five members, PLK1 through PLK5, have been implicated in cancer progression, and their inhibition is being actively explored for cancer management. Although past studies of the PLK family are largely confined to their role in the cell cycle and corresponding chromatin dynamics, recent research has unveiled important connections between PLKs and cancer immunity, particularly in relation to critical signaling pathways such as interferon (IFN) signaling, immunogenic cell death, transforming growth factor beta (TGFβ) signaling, and FAS/FASL signaling. Although much of the research has focused on PLK1, additional members of the PLK family are beginning to attract attention due to their potential implications in cancer immunity. Understanding the intricate role of PLKs in cancer immunity is an emerging field with tremendous potential. This review offers a comprehensive overview of current knowledge connecting the members of the PLK family with cancer immunology and provides considerations for further research to uncover how PLK signaling can be strategically targeted to optimize cancer immunotherapy and enhance clinical responses.Keywords
All Related Versions
Funding Information
- U.S. Department of Veterans Affairs (CSR&D I01CX002210)
- U.S. Department of Veterans Affairs (BLR&D I01BX005917)
- U.S. Department of Veterans Affairs (BLR&D IK6BX006041)
- National Institutes of Health (R01CA261937)
- U.S. Department of Veterans Affairs (I01CX002308)
This publication has 148 references indexed in Scilit:
- Genotoxic Stress-Induced Activation of Plk3 is Partly Mediated by Chk2Cell Cycle, 2002
- Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal CancerAnnals of Surgical Oncology, 2001
- Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving BidMolecular and Cellular Biology, 2000
- The Hallmarks of CancerCell, 2000
- Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase PlkProceedings of the National Academy of Sciences, 1998
- Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progressionBiochemical Journal, 1998
- Cleavage of FLICE (caspase‐8) by granzyme B during cytotoxic T lymphocyte‐induced apoptosisEuropean Journal of Immunology, 1997
- Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation.Proceedings of the National Academy of Sciences, 1994
- Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5Journal of Cell Science, 1994
- [On molecular biology of triglycerides].1966